医学
银屑病
重症监护医学
糖尿病
疾病
共病
慢性阻塞性肺病
银屑病性关节炎
专家意见
大流行
慢性肝炎
传染病(医学专业)
免疫学
2019年冠状病毒病(COVID-19)
内科学
病毒
内分泌学
作者
Clara De Simone,Maria Concetta Fargnoli,Paolo Amerio,Luca Bianchi,Maria Esposito,Federico Pirro,Concetta Potenza,Federica Ricceri,Franco Rongioletti,Luca Stingeni,Francesca Prignano
标识
DOI:10.1080/1744666x.2021.1997592
摘要
In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may be due to psoriasis itself, immunomodulatory therapy, and comorbidities that may increase this risk and patient hospitalization.Given the greater understanding of psoriasis pathogenesis and the increasing number of treatment options, it is particularly important to customize therapy according to each, single patient; psoriasis features and comorbidities are also essential to tailor treatment goals.In this perspective, the current knowledge on the infectious risk in psoriatic patient, related to comorbidities, such as diabetes mellitus, cardiovascular disease, and chronic obstructive pulmonary, to 'special populations,' to chronic infections, such as latent tuberculosis, chronic hepatitis B and C, and HIV, and to the most recent Covid-19 pandemic scenario, is reviewed and discussed in order to suggest the most appropriate approach and achieve the best available therapeutic option.
科研通智能强力驱动
Strongly Powered by AbleSci AI